Hermann Laferl

Human recombinant soluble ACE2 in severe COVID-19

Alexander Zoufaly, Marko Poglitsch, Judith H. Aberle et al. · The Lancet Respiratory Medicine · 2020 · 419 citations · Full text

Covid-19 Pandemic, Immunology, Severe Covid-19 +4

Peginterferon Alfa-2a and Ribavirin for 24 Weeks in Hepatitis C Type 1 and 4 Patients With Rapid Virological Response

Péter Ferenci, Hermann Laferl, Thomas–Matthias Scherzer et al. · Gastroenterology · 2008 · 252 citations · Full text

Hepatology, Hepatitis C, Viral Hepatitis +8

Epidemiology and Clinical Features of Imported Dengue Fever in Europe: Sentinel Surveillance Data from TropNetEurop

Nikolai Mühlberger, Gundel Harms, M Corachán et al. · Clinical Infectious Diseases · 2002 · 170 citations · Full text

Imported Dengue Fever, Vector-borne Pathogen, Infectious Disease Epidemiology +14

Acute Encephalopathy Associated with Influenza A Virus Infection

Christoph Steininger, Theresia Popow‐Kraupp, Hermann Laferl et al. · Clinical Infectious Diseases · 2003 · 119 citations · Full text

Influenzal Encephalopathy, Viral Diagnostics, Viral Pathogenesis +10

Peginterferon Alfa-2a/Ribavirin for 48 or 72 Weeks in Hepatitis C Genotypes 1 and 4 Patients With Slow Virologic Response

Peter Ferenci, Hermann Laferl, Thomas–Matthias Scherzer et al. · Gastroenterology · 2009 · 118 citations

Slow Virologic Response, Hepatology, Hepatitis C +9